CFTR and lung adenocarcinoma: Our results demonstrate that ivacaftor significantly reduced the proliferation of lung adenocarcinoma cells, corroborating that CFTR activity is mechanistically involved in cancer pathogenesis and acts as a pharmacologically targetable tumor suppressor.